ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Anesthesiology and Animal Pain Management
This article is part of the Research TopicInnovations in Hemodynamic Monitoring in Veterinary Medicine: From Macrohemodynamics to MicrocirculationView all articles
Endothelial glycocalyx thickness in cats with naturally occurring trauma or non-traumatic illness – an exploratory study
Provisionally accepted- 1School of Veterinary Sciences, College of Sciences, Massey University, Palmerston North, New Zealand
- 2Shikoku Veterinary Medical Center, Miki 761-0701, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Introduction: Endothelial glycocalyx damage contributes to morbidity and mortality in critical illness. In this exploratory study in cats with trauma and non-traumatic illness, the endothelial glycocalyx thickness was estimated using sidestream dark field videomicroscopy and the GlycocheckTM software, with the primary aims of assessing feasibility, describing of GlycocheckTM microcirculatory parameters and exploring potential effects of illness severity and IV fluid administration. Methods: This was a prospective, single centre, observational study. Recorded variables included age, weight, diagnosis, length of hospitalization (LOH), packed cell volume (PCV) and IV fluid administration. Each patient was assigned a fast Acute Patient Physiologic and Laboratory Evaluation score (APPLEfast) and for cats with trauma - Animal Trauma Triage score (ATT). Within 24h from admission, cats were anaesthetised, and images from the sublingual mucosal vessels obtained for GlycocheckTM analysis. The perfused boundary region (PBR), an inverse estimate for endothelial glycocalyx thickness, was calculated for vessels with diameter of 5-25, 5-9, 10-19 and 20-25 µm, respectively. Normality was assessed using Shapiro-Wilk test and histograms. The effects of APPLEfast, LOH, ATT, PCV, IV fluid administration, and illness group on PBR were analysed using generalised linear models. Distribution of vascular segment counts was assessed using Friedman's test and Wilcoxon rank-signed test. Results: Nineteen cats were included, 11 with trauma. Success rate for measurements was 95%. Survival to discharge was 95%. Mean ± standard deviation for PBR 5-25 was 2.60±0.22 µm, PBR 5-9: 1.38±0.15 µm, PBR 10-19: 3.02±0.22 µm and PBR 20-25: 3.03±0.38 µm, within previously established tolerance intervals. There were no statistically significant effects of group, LOH, ATT, APPLEfast, PCV and IV fluids on any PBR measurements. Vascular segment counts across the 5 – 25 µm range were not equally distributed (p<0.001). Conclusion: This exploratory study demonstrates the feasibility of assessing endothelial glycocalyx thickness in hospitalized sick cats. While no effects of clinical variables on PBR were identified, the study highlights important methodological considerations and provides valuable insights to guide future, larger-scale investigations.
Keywords: APPLEfast, Att, Capillaries, feline, GlycoCheckTM, Length of hospitalisation, Microcirculation, Perfused boundary region
Received: 21 Nov 2025; Accepted: 15 Jan 2026.
Copyright: © 2026 Yozova, Thomson, Irie, Owen and Munday. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ivayla Danielova Yozova
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
